The 40 organizations, representing neuroscience researchers and clinicians as well as patients living with neurological conditions, write to express our significant concern regarding Dr. Walter Koroshetz, Director of the National Institute of Neurological Disorders and Stroke (NINDS) at the National Institutes of Health (NIH), not being renewed for another five-year term.
This action was undertaken despite the positive recommendation to renew Dr. Koroshetz’s term by NIH’s review panel, and the endorsement to do so by the NIH Director, Dr. Jayanta “Jay” Bhattacharya.
Given Dr. Koroshetz’s record of identifying and supporting promising and important research, the community is concerned by the unnecessary disruption caused by his absence, especially without a clear succession plan for NINDS leadership. NINDS is a crucial institute at NIH that directs and funds research into conditions of the brain and central nervous system that impact one in two Americans, including Alzheimer’s disease, stroke, concussion, epilepsy, Parkinson’s disease, multiple sclerosis, headache, and migraine, among others.
Read the Full Letter